The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. CorMedix Inc shares valued at $260,000 were sold by DUNTON ALAN W on Dec 30 ’25. At $13.00 per share, DUNTON ALAN W sold 20,000 shares. The insider’s holdings dropped to 40,250 shares worth approximately $0.29 million following the completion of this transaction.
Also, Alan Dunton purchased 20,000 shares, netting a total of over 259,400 in proceeds.
Before that, Todisco Joseph had sold 30,000 shares from its account. In a trade valued at $360,000, the Chief Executive Officer traded CorMedix Inc shares for $12.00 each. Upon closing the transaction, the insider’s holdings decreased to 30,000 shares, worth approximately $3.61 million.
As published in a research note from D. Boral Capital on October 20, 2025, CorMedix Inc [CRMD] has been rated up from a Hold to a Buy and the price target has been revised to $14. Analysts at H.C. Wainwright started covering the stock with ‘”a Buy”‘ outlook in a report released in late June. As of June 30, 2025, D. Boral Capital has decreased its “Buy” rating to a “Hold” for CRMD. Earlier on March 07, 2025, Leerink Partners initiated its rating. Their recommendation was “an Outperform” for CRMD stock.
Analyzing CRMD Stock Performance
On last trading session, CorMedix Inc [NASDAQ: CRMD] rose 0.42% to $7.09. The stock’s lowest price that day was $7.035, but it reached a high of $7.44 in the same session. During the last five days, there has been a drop of approximately -36.53%. Over the course of the year, CorMedix Inc shares have dropped approximately -36.24%.
Is CorMedix Inc subject to short interest?
Stocks of CorMedix Inc saw a sharp steep in short interest on 2025-12-31 dropping by -0.38 million shares to 16.7 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 17.08 million shares. A decline of -2.27% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 6.2 of the overall float, the days-to-cover ratio (short ratio) decline to 6.2.
Which companies own the most shares of CorMedix Inc (CRMD)?
In terms of CorMedix Inc share price expectations, FactSet research, analysts set an average price target of 17 in the next 12 months, up nearly 140.79% from the previous closing price of $7.06. Analysts anticipate CorMedix Inc stock to reach 22 by 2026, with the lowest price target being 16. In spite of this, 2 analysts ranked CorMedix Inc stock as Buy at the end of 2026. On January 13, 2025, D. Boral Capital assigned a price target of “a Buy” to the stock and initiated coverage with a $15.
